Clinical Trial Update: cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer

View source ↗

Summary

A clinical trial is evaluating cfDNA 5mC/5hmC biomarkers to predict chemotherapy response in metastatic colorectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: CRC (Colorectal Cancer) | Status: RECRUITING